The Blog

Neurana Pharmaceuticals Announces Publication of a Driving Study Conducted by CNS Research

May 12, 2020 — Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced the publication of a driving study which demonstrates the tolerability and safety of tolperisone in the peer-reviewed Journal of Clinical Pharmacy and Therapeutics. The publication, “An assessment of the centrally acting muscle relaxant tolperisone on…

Read More

CoVlD-19 (Coronavirus): Risk Mitigation & Response Plans

CoVlD-19 (Coronavirus): Risk Mitigation & Response Plans   APEX COVID-19 Response Documents   As our communities battle COVID-19, CNS Research and Hassman Research Institute, now collectively Apex Innovative Sciences, remain committed to upholding our promises to you in the conduct of your trials and all sites remain open and actively screening new subject and conducting…

Read More

CNS Research Praised for Excellent Work Under Difficult Circumstances

Good news is appreciated at this difficult time. Here’s what our CNS Research site got from one of our sponsors today: I will say that we are all very impressed with the site’s professionalism during this very challenging time.  Their professionalism is remarkable and noted through our organization.  As a former health care provider (I…

Read More

What You Need To Know About Handwashing

This video answers important questions about hand washing and hand sanitizer. 

Read More

COVID-19 Action Updates

    COVID-19 Action Updates Please know that our Executive Management Team, our Chief Compliance Officer and all Apex staff are taking subject and employee safety seriously. Below are some measures we’ve taken, with new initiatives daily as needed to address an evolving situation. Apex leadership has shared best practices for dealing with this crisis…

Read More

CNS Network and Hassman Research Institute Complete Strategic Merger

  CNS Network and Hassman Research Institute Complete Strategic Merger to Form Apex Innovative Sciences, Inc.   Marlton, NJ and Garden Grove, CA (October 1, 2019). CNS Network (“CNS”) and Hassman Research Institute (“HRI”) have completed a strategic merger to form Apex Innovative Sciences, Inc. (“Apex” or the “Company”). The combination represents the industry leading…

Read More

Alliance Hosts Placebo Mitigation Webinar by Elan Cohen, Ph.D.

Dr. Elan Cohen is a PI at Hassman Research Institute with ample experience in rater training and data surveillance. He is also significantly engaged in research exploring various interventions aimed at systemically reducing the insidious placebo and nocebo effects within clinical trials (http://www.hritrials.com/hri-science-division-2/). Dr. Cohen conducted two separate presentations to attendees from each Alliance site…

Read More

Recorded Webinar: “Driving Impairment: Avoiding Roadblocks in Drug Development”

Thanks to all who participated in our recent webinar, “Driving Impairment: Avoiding Roadblocks in Drug Development.” If you missed it, a recording of the presentation is available. If you have a compound in development that has potential to impair driving ability, this is necessary information. Attending DIA or ASCP? Don’t miss the chance to experience…

Read More

Steven Glass, M.D. Joins Hassman Research Institute as Psychiatric Medical Director

BERLIN, NJ, April 23, 2019 — We are pleased to announce that Steven J. Glass, M.D. has joined Hassman Research Institute (HRI) as Psychiatric Medical Director. Dr. Glass received his medical degree from Thomas Jefferson Medical College in Philadelphia (now Sidney Kimmel Medical College of Jefferson University) where he also completed his psychiatric residency and…

Read More

Exemplar Research partners with Clinical Trial Centers Alliance

Clinical Trial Centers Alliance, an elite group of independent sites and services, is pleased to announce the addition of Exemplar Research, Inc., a community-based, independent Regional Investigative Clinical Research Site Network, serving West Virginia and the surrounding region. Exemplar will benefit from the resources of the Alliance’s successful history serving hundreds of sponsors, CROs and…

Read More
Page 1 of 1012 »